FTC pursues firms advertising "free" product trials
This article was originally published in The Tan Sheet
Executive Summary
The Federal Trade Commission follows through with its promise to enforce against marketers that falsely promise "free" product trials. The commission says it will announce Aug. 16 a lawsuit against a firm that allegedly marketed free trials of acai berry weight-loss and colon-cleansing supplements. FTC warned in February 2009 it would pursue firms that enrolled consumers in a "negative option" continuity program under which consumers are charged without consent for reoccurring shipments unless the consumer cancels. Marketers advertising acai products with negative option schemes caught the attention of Connecticut Attorney General Richard Blumenthal, the Center for Science in the Public Interest and the Council of Better Business Bureaus (1"The Tan Sheet" March 30, 2009)
You may also be interested in...
Acai Offered As Bait In Latest Marketing Scams To Draw Investigations
Trendy supplement ingredient acai is the latest lure in what the Federal Trade Commission calls "negative-option" online marketing scams
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.